XML 66 R51.htm IDEA: XBRL DOCUMENT v3.8.0.1
Related Party Transactions - Additional Information (Detail) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 12 Months Ended
May 31, 2016
Jul. 31, 2014
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Aug. 31, 2015
Related Party Transaction [Line Items]                            
Research and development expense related to license and service agreements with related party     $ 21,170 $ 17,481 $ 15,565 $ 13,431 $ 11,331 $ 7,861 $ 7,423 $ 5,225 $ 67,647 $ 31,840 $ 11,170  
General and administrative expenses     10,213 5,711 6,369 5,732 5,118 4,705 3,729 3,246 28,025 16,798 8,283  
Collaboration revenue     $ 6,668 $ 7,317 $ 5,917 $ 6,215 5,627 $ 4,869 $ 4,206 $ 1,777 $ 26,117 $ 16,479 $ 6,044  
Class A-2 Preferred Units [Member]                            
Related Party Transaction [Line Items]                            
Common stock, shares acquired                         1,333,333  
Caribou [Member]                            
Related Party Transaction [Line Items]                            
Junior preferred units issued   8,110,599                        
Percentage of related party obligation   30.00%                 30.00% 30.00% 30.00%  
Percentage of shares owned     10.70%               10.70%      
Research and development expense related to license and service agreements with related party                       $ 1,300 $ 1,500  
Current obligations related to license and service agreements with related party                         600  
General and administrative expenses                     $ 500 900 1,100  
Novartis [Member] | Collaborative Arrangement [Member]                            
Related Party Transaction [Line Items]                            
Percentage of shares owned     9.70%               9.70%      
Common stock, shares acquired 277,777                          
Collaboration revenue                     $ 9,300 7,800 $ 6,000  
Accounts receivable     $ 6,000       6,000       6,000 6,000    
Deferred revenue     $ 11,200       $ 11,600       $ 11,200 $ 11,600    
Novartis [Member] | Class A-1 Preferred Units [Member] | Collaborative Arrangement [Member]                            
Related Party Transaction [Line Items]                            
Junior preferred units issued   4,761,905                        
Novartis [Member] | Class A-2 Preferred Units [Member] | Collaborative Arrangement [Member]                            
Related Party Transaction [Line Items]                            
Junior preferred units issued   2,666,666                        
Novartis [Member] | Series B Preferred Stock [Member] | Collaborative Arrangement [Member]                            
Related Party Transaction [Line Items]                            
Preferred stock, shares acquired                           761,905